Beijing Wantai (China) Today
| 603392 Stock | 68.10 3.57 4.98% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Beijing Wantai is trading at 68.10 as of the 26th of February 2025, a 4.98 percent decrease since the beginning of the trading day. The stock's open price was 71.67. Beijing Wantai has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Moving against Beijing Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Beijing Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Beijing Wantai's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Beijing Wantai or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| GM Chairman | Zixin Qiu |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Beijing Wantai Biological (603392) is traded on Shanghai Stock Exchange in China and employs 3,843 people. Beijing Wantai is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 84.93 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Beijing Wantai's market, we take the total number of its shares issued and multiply it by Beijing Wantai's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Beijing Wantai Biological operates under Biotechnology sector and is part of Health Care industry. The entity has 1.27 B outstanding shares.
Beijing Wantai generates positive cash flow from operations, but has no cash available
Check Beijing Wantai Probability Of Bankruptcy
Ownership AllocationBeijing Wantai holds a total of 1.27 Billion outstanding shares. Beijing Wantai Biological shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.86 percent of Beijing Wantai Biological outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Beijing Ownership Details
Beijing Wantai Biological Risk Profiles
Although Beijing Wantai's alpha and beta are two of the key measurements used to evaluate Beijing Wantai's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.38 | |||
| Standard Deviation | 2.01 | |||
| Variance | 4.02 | |||
| Risk Adjusted Performance | (0.02) |
Beijing Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beijing Wantai without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Beijing Wantai Corporate Directors
| Lingzhi Zhao | Deputy Director | Profile | |
| Yun Lu | Financial Director | Profile | |
| Zhiming Jiang | MD Director | Profile | |
| Xiangzhong Ye | Deputy Director | Profile |
Other Information on Investing in Beijing Stock
Beijing Wantai financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Wantai security.